Servier

Attending #BIOEurope? 🌍 Let’s meet in Cologne, Nov 9–11!
Servier teams will be there to connect with innovative companies and explore new collaborations in #Oncology and #Neurology.
🎤 Don’t miss Marine Beurdeley, Global Business Development Lead, Neurology, who will join the panel discussion “Networks or neurons: What’s next in CNS deal making?“ on 🗓️ Nov 10, 09:00 - 09:45 am CET and deliver a presentation introducing Servier and our partnering ambitions 🗓️ the same day - 10:30 – 10:45 am CET (Location: Business of Biotech Stage).
Learn more about our partnering strategy 🔗 f.mtr.cool/rpchqfkgaq
#Innovation #Healthcare

#ESMO26 is now over! We were pleased to share the latest in #oncology science 🧬 and up‑to‑date education 📚. In line with our #Servier2030 ambition, our #research 🔬 is focused on rare #cancers 🎗️ to address high unmet medical needs among #patients 🩺. @myESMO 
Learn more about our commitment to oncology 🔗 f.mtr.cool/z8y3k2kvrr

🧠 International Brain Tumour Awareness Week has begun.
At Servier, we are committed to advancing research in rare cancers, including gliomas, to bring innovative therapeutic solutions to patients who need them most.
Learn more 👉 f.mtr.cool/57yq3a028z
#BrainTumor #IBTAWeek #BrainTumourAwareness #WeAreServier #MovedByYou

👋 We’re attending #ESMO26! 
For over 10 years, #oncology has been our top priority — close to 70% of our R&D budget is dedicated to advancing cancer research. Today, our pipeline includes 36 projects, with a strong focus on rare #cancers.
Meet us at booth No. 8064 🏢 and join our symposiums to learn more.
Discover our commitment to oncology 🔗 f.mtr.cool/j3236wrjk8
#CancerResearch #patient @myESMO

💜 October is KCNT1 Awareness Month!
At Servier, we proudly support KCNT1 Epilepsy Foundation’s campaign to raise awareness of this rare epilepsy which affects young children
Neurology is now a key focus of our #Servier2030 strategy, with 14 active R&D projects.
🔗 f.mtr.cool/o4bm3dnnkz
#KCNT1 #Neurology #WeAreServier